BioCorRx Inc. (BICX) stock
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
$0.25+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.30MP/E –Yield –
BioCorRx ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
BioCorRx's ebitda for the twelve months ending Jun 30, 2026 was -$4.93M. For fiscal 2025 it was -$4.79M. The highest annual figure on record is -$2.15M in fiscal 2016.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.79M | – |
| FY2024 | Dec 31, 2024 | -$5.09M | – |
| FY2023 | Dec 31, 2023 | -$3.76M | – |
| FY2022 | Dec 31, 2022 | -$4.67M | – |
| FY2021 | Dec 31, 2021 | -$5.45M | – |
| FY2020 | Dec 31, 2020 | -$7.41M | – |
| FY2019 | Dec 31, 2019 | -$5.53M | – |
| FY2018 | Dec 31, 2018 | -$4.62M | – |
| FY2017 | Dec 31, 2017 | -$2.86M | – |
| FY2016 | Dec 31, 2016 | -$2.15M | – |
| FY2015 | Dec 31, 2015 | -$4.99M | – |
| FY2014 | Dec 31, 2014 | -$2.92M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.46M | – |
| Q1 FY2026 | Mar 31, 2026 | -$944.81K | – |
| Q4 FY2025 | Dec 31, 2025 | -$658.99K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.87M | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$913.10K | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.11M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.65M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.36M | – |
| Q1 FY2024 | Mar 31, 2024 | -$961.98K | – |
| Q4 FY2023 | Dec 31, 2023 | -$816.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$955.15K | – |
| Q2 FY2023 | Jun 30, 2023 | -$940.19K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.05M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.12M | – |
| Q2 FY2021 | Sep 30, 2021 | -$2.56M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.56M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.75M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.03M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.14M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.58M | – |
| Q3 FY2019 | Sep 30, 2019 | -$879.09K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.60M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.48M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.94M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.40M | – |
| Q2 FY2018 | Jun 30, 2018 | -$740.15K | – |
| Q1 FY2018 | Mar 31, 2018 | -$535.51K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.02M | – |
| Q3 FY2017 | Sep 30, 2017 | -$655.10K | – |
| Q2 FY2017 | Jun 30, 2017 | -$778.15K | – |
| Q1 FY2017 | Mar 31, 2017 | -$403.95K | – |
| Q4 FY2016 | Dec 31, 2016 | -$909.16K | – |
| Q3 FY2016 | Sep 30, 2016 | -$497.03K | – |
| Q2 FY2016 | Jun 30, 2016 | -$411.50K | – |
| Q1 FY2016 | Mar 31, 2016 | -$334.08K | – |
| Q4 FY2015 | Dec 31, 2015 | -$667.28K | – |
See a number that looks wrong?